Global stomach cancer market is estimated to reach USD 6.5 billion by 2026 at a CAGR of 5.7% during the forecast period 2019–2026

Stomach Cancer Market

Stomach cancer, also known as gastric cancer, is the third leading cause for cancer-related deaths across the globe. Several genetic, infectious, environmental, and immunologic factors are known to cause stomach cancer. With the increasing prevalence of gastric cancer, it has become crucial for FDA to approve the launch of new and orphan drugs in the market.  In  August 2018, Alteogen Inc, a South Korean biotechnology company, received  FDA approval for orphan drug designation for antibody-drug conjugate (ALT-P7) that would strengthen the cancer treatment further.

The Major Players Covered in this Report:
Novartis International AG, Eli Lilly, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck KGaA, and Otsuka Holdings Co. Ltd. 

Global stomach cancer market is estimated to reach USD 6.5 billion by 2026 at a CAGR of 5.7% during the forecast period 2019–2026.

Get a Sample PDF Report:
https://straitsresearch.com/report/Stomach-Cancer-market/request-sample

By Therapy, Targeted drug therapy,Chemotherapy,Surgery

By End User,Hospitals & clinics,Specialty clinics, Ambulatory Services

Segmentation Insights

Global stomach cancer market is segmented by therapy, end-users, and regions.

By therapy, the stomach cancer market is segmented into targeted drug therapy, chemotherapy, and surgery.
Chemotherapy is one of the most popular and the second largest treatment used for treating stomach cancer. It is used along with monotherapy, combination therapy, and radiation therapy. 5-FU (fluorouracil), cisplatin, epirubicin, and oxaliplatin are some of the commonly used drugs in chemotherapy. In February 2019, US FDA has approved trifluridine/tipiracil (Lonsurf) for stomach cancer treatment. According to the survey conducted by WHO, around 5 out of every 10 neuroendocrine tumors starts in the stomach and is responsible for 783,000 deaths. According to the National Cancer Institute, the age-adjusted incidence of carcinoid tumors across the globe is approximately 2 per 100,000 persons with the average age of diagnosis 61.4 years. Additionally, carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.

Regional Analysis For Stomach Cancer Market:

North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Stomach Cancer are as follows:

History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2021 to 2026

The study objectives of this report are:

To study and forecast the market size of the Stomach Cancer in the global market.
To analyze the global key players, SWOT analysis, value, and global market share for top players.
To define, describe and forecast the market by type, end-use, and region.
To analyze and compare the market status and forecast among global major regions.
 Analyze the potential of the global market and the advantages, opportunities and challenges, constraints, and risks of key regions.
Identify the key trends and factors that are driving or holding back market growth.
To analyze the opportunities in the market for stakeholders by identifying the high-growth segments.
Strategic analysis of each submarket in light of individual growth trends and market contributions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Complete analysis of the strategic strategy and growth of key players

For More Details On this Report:
https://straitsresearch.com/report/Stomach-Cancer-market

Contact Us:

Company Name: Straits Research
Email: sales@straitsresearch.com
Phone:
+1 646 480 7505 (U.S.)
+91 8087085354 (India)
+44 208 068 9665 (U.K.)

About Us:

Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs. Moreover, we're continually developing, not only with regards to where we measure, or who we measure but in how our visions can enable you to drive cost-effective growth.

This release was published on openPR.